Same Day Delivery Across Bali
Research Methodology

How to Read a Certificate of Analysis and Why Purity Percentage Matters

Published: June 12, 2026
9 min read
How to Read a Certificate of Analysis and Why Purity Percentage Matters
Research Disclaimer: BioPepTech products are supplied strictly for research use only. They are not intended for human consumption and are not intended to diagnose, treat, cure, or prevent disease.

Summary

A practical guide to understanding a peptide Certificate of Analysis (CoA), what each section means, how purity percentage is measured, and why it matters for research integrity.

BioPepTech products are supplied strictly for research use only. They are not intended for human consumption and are not intended to diagnose, treat, cure, or prevent disease.

Quick Summary

A Certificate of Analysis (CoA) is a document issued by an analytical laboratory that confirms the identity, purity, and quality of a compound. For research peptides, a valid CoA is the primary evidence that what is written on the vial label matches what is actually inside.

Knowing how to read a CoA means being able to distinguish between a supplier that has genuinely tested their product and one that has simply printed a number on a website. This guide explains every section of a standard peptide CoA, what the purity percentage actually measures, what other tests should accompany purity data, and what to look for when evaluating a document's legitimacy.

What Is a Certificate of Analysis?

A Certificate of Analysis is a formal quality document issued by an analytical laboratory after testing a specific batch of compound. It records the results of one or more analytical methods applied to that batch.

A CoA is always batch-specific. It applies to one production lot and one lot only. The lot number on the CoA must match the lot number printed on or attached to the physical vial.

A CoA from a different lot, a different date, or with no lot number at all provides no reliable information about the vial in your hands.

Who issues a CoA?

The most trustworthy CoAs are issued by independent third-party laboratories — organisations with no commercial interest in the outcome of the test. When a supplier tests their own products in-house without external verification, there is no way to independently confirm the result.

BioPepTech works exclusively with Horizon Analytical, an independent laboratory, for all batch testing. The CoA, mass spectrometry report, and endotoxin test results are published per batch so the lot number can be traced directly back to the test data.

The Anatomy of a Peptide CoA

1. Laboratory name and accreditation

The document header should clearly identify the issuing laboratory. Look for accreditation credentials such as ISO/IEC 17025, which is the international standard for testing laboratories. Accreditation means the laboratory's methods, equipment, and personnel have been externally audited and verified.

A CoA with no laboratory name, no contact information, or no accreditation reference is not a reliable document.

2. Client and compound information

This section identifies:

  • The supplier or client who submitted the sample
  • The compound name
  • The CAS number (if applicable)
  • The lot or batch number
  • The sample receipt date

The lot number is the critical link between the CoA and the physical vial. If these do not match, the CoA is irrelevant to the sample being tested.

3. Test date and report date

Both dates should be present. The test date confirms when the analysis was actually performed. The report date is when the document was issued.

Be cautious of CoAs with very old test dates. Peptide purity can change over time, particularly if storage conditions have not been maintained correctly. A batch tested two or three years ago and stored improperly may no longer match its original CoA results.

4. Analytical method

The CoA should state which method was used to determine purity. For peptides, the two most common methods are:

MethodWhat it measures
HPLC (High-Performance Liquid Chromatography)Separates components in a mixture; measures each peak's area as a percentage of the total
UPLC (Ultra-Performance Liquid Chromatography)A faster, higher-resolution variant of HPLC; increasingly standard for peptide analysis

Both HPLC and UPLC are chromatographic techniques that work by passing a dissolved sample through a column that separates its components by their chemical properties. The detector then measures how much of each component is present relative to the whole.

The method name and column details should appear on the CoA. A document that states only "purity tested" without naming the method cannot be independently evaluated.

5. Purity percentage

This is usually the number most prominently displayed — and the one most commonly misunderstood.

The purity percentage produced by HPLC or UPLC represents the chromatographic purity: the fraction of the detected signal that corresponds to the target peptide, expressed as a percentage of all detected signals.

A result of 99% purity means that 99% of what the detector detected was the target peptide. The remaining 1% includes other detectable compounds — which may be residual synthesis by-products, truncated sequences, or related impurities.

What purity does not measure:

  • It does not confirm that the compound is the correct peptide (that requires mass spectrometry)
  • It does not confirm the absence of undetectable contaminants such as endotoxins
  • It does not account for compounds present below the detector's sensitivity threshold

This is why purity percentage alone is necessary but not sufficient for evaluating a research peptide.

6. Identified impurities

A high-quality CoA will not only give the purity percentage but also list the individual impurities detected above the reporting threshold, typically expressed as a percentage of total area. This level of detail allows a researcher to assess whether any identified impurity is relevant to their specific research application.

7. Water content (Karl Fischer)

Lyophilized peptides always contain a small amount of residual moisture. The Karl Fischer titration test measures this water content as a percentage of the total sample weight.

Why does this matter? A peptide vial labelled as containing 10 mg may have a water content of, say, 8%. This means the actual peptide content is approximately 9.2 mg — the remaining 0.8 mg is water. For research requiring precise dosing, knowing the water content allows for more accurate calculation of actual peptide mass.

Not all suppliers include this test. Its presence on a CoA is a mark of thoroughness.

8. Counterion content (TFA or acetate)

Peptides produced by solid-phase synthesis often contain trifluoroacetate (TFA) as a counterion from the purification process. TFA itself has been associated with biological activity in some research contexts, which can confound experimental results.

A complete CoA may include TFA content as a percentage of the sample. Some manufacturers offer TFA-removed or acetate-form peptides for research applications where this is a concern.

Why Purity Percentage Matters

Research reproducibility

If a peptide is only 85% pure rather than 99% pure, the actual amount of the target compound in each measured dose is lower — and the remaining 15% is an undefined mixture of impurities. Results from research conducted with lower-purity material are harder to reproduce and harder to compare against published literature that used higher-purity material.

Dose accuracy

Impurities dilute the active compound. A nominal 5 mg vial at 85% purity contains approximately 4.25 mg of the target peptide and 0.75 mg of other substances. At 99% purity, the same vial contains 4.95 mg of target peptide. For research protocols where precise dosing matters, this difference is significant.

Safety of the research process

In research involving cell cultures, animal models, or in vitro assays, impurities can generate confounding signals. An unexpected result may be caused not by the target compound but by an uncharacterised impurity at a meaningful concentration.

Purity benchmarks

PurityResearch context
Below 95%Generally considered insufficient for rigorous research
95% to 98%Acceptable for exploratory research
98% to 99%Suitable for most research applications
Above 99%High-grade; appropriate for demanding research protocols

BioPepTech sets a minimum internal standard of 99% chromatographic purity for all compounds in its catalog.

The Three Documents You Should Always Request

Purity alone does not confirm that a peptide is the right compound, is sterile, and is safe to handle in a laboratory environment. A complete analytical package for a research peptide should include three documents:

Certificate of Analysis (CoA)

Confirms purity by HPLC or UPLC. Establishes that the bulk of the detectable material is the target compound at or above the stated percentage.

Mass Spectrometry Report (MS)

Confirms molecular identity. Mass spectrometry measures the molecular weight of the compound and produces a characteristic spectrum. For a peptide, this confirms that the compound has the correct molecular mass and fragmentation pattern for the claimed sequence.

Mass spectrometry and chromatographic purity together provide strong evidence of both identity and quality. A high purity reading alone does not rule out the possibility that a high-purity sample is a high-purity version of the wrong compound. Mass spectrometry closes that gap.

Endotoxin Test (LAL)

Confirms the absence of bacterial endotoxins above the threshold. Endotoxins are fragments of gram-negative bacterial cell walls that can trigger strong inflammatory responses and interfere with cell-based assays. Even a chemically pure, correctly identified peptide can produce unreliable research results if it carries significant endotoxin contamination.

The Limulus Amebocyte Lysate (LAL) test is the standard method for endotoxin detection. Results are expressed in Endotoxin Units per millilitre (EU/mL). BioPepTech's standard is below 0.05 EU/mL for all batches.

Red Flags to Watch For

No lot number on the CoA

A CoA without a lot number cannot be matched to any specific batch. It may be a generic document applied across multiple production runs.

Lot number does not match the vial

Always cross-reference the lot number on the CoA with the number on the vial sticker or accompanying documentation. A mismatch means the CoA does not apply to the compound you received.

No laboratory name or contact details

A legitimate laboratory stands behind its results with identifiable contact information. Anonymous testing documents cannot be followed up or verified.

Unusually old test date

Purity data from years ago may not reflect the current condition of a stored batch, particularly if cold chain conditions cannot be verified across that period.

Only purity provided — no MS, no endotoxin

A supplier that provides only a purity percentage without mass spectrometry confirmation and endotoxin testing has completed only one third of the minimum analytical requirements for a research-grade peptide.

Round numbers with no decimal

A purity result expressed as a clean "99%" with no decimal places (e.g., 99.14% or 98.73%) may indicate a rounded or estimated figure rather than an actual chromatographic measurement.

How to Verify a CoA Is Genuine

Match the lot number

The lot number on the CoA must match the lot number on the physical product. This is the first and most basic verification step.

Contact the laboratory directly

A genuinely independent laboratory should be contactable. If the supplier provides a CoA but cannot provide the laboratory's name, website, or contact details, that is a significant red flag.

Look for consistent formatting

Legitimate laboratory documents follow consistent, professional formatting with logos, addresses, analyst signatures, and instrument reference numbers. A CoA that appears to have been assembled in a word processor without laboratory identifiers is not a valid analytical document.

Request the raw data or chromatogram

A properly conducted HPLC or UPLC analysis produces a chromatogram — a graphical output showing the peaks detected. A supplier that has genuinely tested their product should be able to provide the chromatogram alongside the CoA. This level of transparency is the clearest signal of genuine third-party testing.

Frequently Asked Questions

What does 99% purity mean on a peptide CoA?

It means that 99% of the chromatographically detectable material in the sample corresponded to the target peptide. The remaining 1% consists of other detectable compounds, which may include synthesis by-products or related impurities.

Is a 99% pure peptide better than a 98% pure peptide for research?

For most research applications, both are suitable. The practical difference becomes more significant in dose-sensitive protocols or assays where impurities could interfere with measurements.

Why is mass spectrometry needed if purity is already tested?

HPLC purity confirms how much of the detectable material is the target. Mass spectrometry confirms that the target is actually the correct compound. A sample could theoretically be 99% pure and still be the wrong peptide.

What is an acceptable endotoxin level for research peptides?

The acceptable level depends on the research context. As a general benchmark, levels below 1 EU/mL are considered low; below 0.1 EU/mL is preferable for cell-based assays. BioPepTech's standard is below 0.05 EU/mL.

Can I trust a CoA with no laboratory name?

No. A CoA without an identifiable issuing laboratory cannot be independently verified. It provides no reliable quality assurance.

How often should a batch be re-tested?

For long-term storage, re-testing at 12-month intervals or after any deviation in storage conditions is considered good practice. An initial CoA does not guarantee purity indefinitely.

Researchers reviewing this topic may also find the following relevant:

  • How to reconstitute peptides: a beginner's guide
  • Retatrutide dosage: research overview and study protocols
  • How retatrutide works: receptor agonism and mechanisms

References

United States Pharmacopeia General Chapter 1058 Analytical Instrument Qualification.

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Q2(R1): Validation of Analytical Procedures: Text and Methodology.

Mant CT, Hodges RS. High-Performance Liquid Chromatography of Peptides and Proteins. CRC Press.

European Pharmacopoeia. Chapter 2.6.14 Bacterial Endotoxins.

Research Use Only Disclaimer

BioPepTech products are supplied strictly for research use only. They are not intended for human consumption and are not intended to diagnose, treat, cure, or prevent disease.

Important Notice: The information detailed above is gathered from publicly available peer-reviewed literature and clinical trials. BioPepTech does not provide medical advice. All products sold are for laboratory research use only.
Share Research: